Johnson & Johnson’s ( JNJ ) revenue and earnings growth are poised to accelerate moving forward. The company's growth should benefit from the ramp-up of TREMFYA, which is successfully replacing STELARA after loss ofI have over 15 years of experience investing and have provided research services to mid-sized hedge funds with assets under management between $100 and $500 million. I also have had a brief stint as a sell-side analyst. I am now focusing primarily on managing my own money and my purpose here is t ...

Core Insights - Johnson & Johnson's revenue and earnings growth are expected to accelerate due to the successful ramp-up of TREMFYA, which is replacing STELARA after its loss of exclusivity [1] Group 1: Revenue and Earnings Growth - The company is poised for revenue and earnings growth acceleration moving forward [1] - The growth is primarily driven by the successful market entry of TREMFYA [1] Group 2: Product Transition - TREMFYA is effectively replacing STELARA, indicating a strategic shift in the company's product lineup [1]

Crypto.com and international investment company Galapagos Capital announced a partnership that will see Galapagos Capital leverage Crypto.com Exchange services and capabilities to establish a new digital asset offering for its clients. Galapagos Capital will now reportedly aim to leverage Crypto.com Exchange for its trading infrastructure as well as liquidity in order to offer improved trading execution to clients through an accessible platform.The Crypto.com Exchange is described as being Crypto.com’s so-c ...

Core Insights - Coinbase has appointed former British finance minister George Osborne to lead its internal advisory council, aiming to enhance its influence in the cryptocurrency sector [1] Company Developments - The appointment of George Osborne is part of Coinbase's strategy to strengthen its advisory capabilities and navigate regulatory challenges in the evolving crypto landscape [1] Industry Context - This move reflects a broader trend in the cryptocurrency industry where companies are seeking experienced leaders from traditional finance to guide their operations and compliance efforts [1]

With U.S. stock futures trading mixed this morning on Thursday, some of the stocks that may grab investor focus today are as follows:Wall Street expects Accenture Plc (NYSE:ACN) to report quarterly earnings at $3.75 per share on revenue of $18.52 billion before the opening bell, according to data from Benzinga Pro. Accenture shares gained 0.2% to $274.27 in after-hours trading.Micron Technology Inc. (NASDAQ:MU) reported better-than-expected earnings for the first quarter of fiscal 2026 and issued a strong o ...

Core Insights - BNP Paribas is in exclusive negotiations to acquire Mercedes-Benz's car-leasing subsidiary, Athlon, with the transaction valued at approximately 1 billion [1] Company Summary - The acquisition involves BNP Paribas, a French bank, and Mercedes-Benz, a German car manufacturer [1] - Athlon, the car-leasing subsidiary of Mercedes-Benz, is the target of this acquisition [1] Financial Details - The transaction is valued at around 1 billion [1]

Core Viewpoint - PureTech Health plc has appointed Robert Lyne as the new Chief Executive Officer (CEO), effective immediately, marking a significant leadership transition for the company [1][2]. Company Leadership - Robert Lyne expressed his honor in leading PureTech at a pivotal moment, emphasizing the strength of the company's programs and the talent of its team [2]. - The Board of Directors supports Lyne's appointment, highlighting his strong leadership and strategic clarity during his tenure as Interim CEO [4]. Strategic Focus - The immediate focus for the company is to secure funding for Celea Therapeutics, following a successful End-of-Phase 2 meeting with the U.S. FDA, with expectations to close funding within the first half of 2026 [3]. - PureTech plans to operate with a streamlined structure and reduced overhead, pursuing capital-efficient innovation initiatives to enhance shareholder returns [4]. Financial Strategy - Once Celea is fully financed, the company will evaluate methods to deliver value to shareholders, including potential capital returns, while maintaining a disciplined investment posture [4]. - The company aims to preserve capital and maintain flexibility to position itself for future value creation [4]. Company Background - PureTech Health is a biotherapeutics company focused on transforming innovation into value through a capital-efficient R&D model, having produced multiple therapeutic candidates, including three that received U.S. FDA approval [6].

Core Viewpoint - Netflix is positioning itself as a competitive buyer against Warner Brothers Discovery (WBD) and is attempting to counter claims of monopolistic dominance in the streaming market [1][2]. Group 1: Netflix and Warner Brothers Discovery - A potential merger between Netflix and Warner Brothers would result in a combined TV viewing share of 9.2% in the US, with HBO and HBO Max contributing 1.2% of that share, which would still not surpass YouTube and Disney [1]. - WBD has recommended its shareholders reject Paramount Sky Dance's all-cash bid of $77.9 billion at $30 per share, indicating confidence in its current strategy [2]. Group 2: Streaming Market Dynamics - Netflix and HBO together account for over 50% of all monthly streaming subscribers globally, and their combined revenue and content budget exceed that of all other competitors [4]. - The only segment of the entertainment industry that is experiencing growth is streaming, highlighting its increasing importance [10]. Group 3: Regulatory Challenges - There is skepticism regarding the survival of a Netflix-WBD merger under regulatory scrutiny, with expectations that various regulatory bodies will block the deal [6][25]. - The political landscape, including potential involvement from figures like Donald Trump, may further complicate the merger's prospects [26][27]. Group 4: Competitive Landscape - Paramount's bid is seen as potentially viable due to its higher offer of $108 billion compared to WBD's valuation, despite WBD's rejection based on doubts about the bid's fulfillment [8][11]. - The competitive dynamics in Hollywood are shifting, with talent expressing concerns about Netflix's influence and the implications of a merger that would consolidate power in the streaming market [20][21].

Core Viewpoint - Uxin Limited reported strong financial results for the quarter ended September 30, 2025, with significant year-over-year growth in retail transaction volume and revenue, indicating a robust recovery and scalability of its business model in the used car retail sector in China [1][4][5]. Financial Performance - Non-GAAP adjusted EBITDA loss was RMB5.3 million (US$0.7 million), an improvement from a loss of RMB16.5 million in the previous quarter and a loss of RMB9.2 million in the same period last year [3][17]. - Total revenue reached RMB879 million (US$123.5 million), up 33.6% from RMB658.3 million in the last quarter and up 76.8% from RMB497.2 million in the same period last year [6][7]. - Retail revenue was RMB819 million (US$115 million), representing an 84% year-over-year growth and a 35% quarter-over-quarter growth [4][8]. - Gross margin improved to 7.5%, the highest in nearly three years, compared to 5.2% in the last quarter and 7.0% in the same period last year [11][14]. Transaction Volume - Retail transaction volume was 14,020 units, up 134% year-over-year and 35% from the previous quarter [4][6]. - Total transaction volume was 15,904 units, an increase of 37% from the last quarter and 125.7% from the same period last year [6]. Superstore Expansion - Uxin opened its fifth superstore in Jinan, Shandong Province, which can display over 1,000 vehicles, further enhancing its market presence in Northern China [20]. - The company has plans for additional superstores in 2026, indicating a strong pipeline for future growth [4][19]. Strategic Partnerships - Uxin entered into strategic partnerships for new superstores in Tianjin, Yinchuan, and Guangzhou, which are expected to enhance its supply chain and service network across northern China [21][22][23]. Business Outlook - For the fourth quarter of 2025, Uxin projects retail transaction volume to exceed 18,500 units, representing over 110% year-over-year growth [4][25]. - The company estimates total revenues for the full year 2025 to exceed RMB3,200 million, reflecting continued strong performance [25].

This new agreement further enhances the reach of the Keepit Partner Network, which empowers resellers, MSPs, and distributors across EMEA, North America, and ANZ to offer secure, cloud-native data protection. To become a Keepit partner in France, contact partner@keepit.com or visit keepit.com/partners. About Keepit Keepit provides a next-level SaaS data protection platform purpose-built for the cloud. Securing data in a vendor-independent cloud safeguards essential business applications, boosts cyber resili ...